dementia-related pscyhosis

Relapse risk for psychosis in dementia lower with continued pimavanserin
Relapse risk for psychosis in dementia lower with continued pimavanserin
Jul 22, 2021

Findings seen in double-blind, randomized, placebo-controlled discontinuation trial that was stopped early for efficacy